Exclusive: Ukraine's anti-graft bureau probes state tender for medical suits

Published 2020-05-25, 07:41 a/m
© Reuters. Employees sew protective suits at the Textile-Contact company's factory in Chernihiv

By Natalia Zinets

KIEV (Reuters) - Ukrainian anti-corruption officials are investigating a tender for 71,000 hospital protective suits during the coronavirus pandemic after the government for the first time bypassed its own procurement rules in the health sector.

Ukraine, long dogged by rampant corruption, has won rare praise from international donors for its efforts to overhaul procurement processes and tackle graft in its health system. The donors' aid, which hinges on Kiev's success in tackling graft, is sorely needed as a deep recession looms.

Asked about the tender, Ukraine's anti-corruption bureau (NABU) told Reuters it was working on a pretrial investigation into possible abuse of office after an unnamed lawmaker raised concerns on the issue. NABU gave no further details, saying that divulging information could harm its investigation.

The head of Medical Procurement of Ukraine (MPU), a state body set up in 2018 to combat corruption in the awarding of health sector contracts, accused the government of violating its own rules by overruling his agency's choice for the tender and awarding the contract to a company that delivered the suits very late and at an inflated price.

"This practice is counterproductive and illegal," Arsen Zhumadilov told Reuters in an interview.

The MPU handles procurement of medicines and medical equipment on behalf of the health ministry.

The health ministry denies any wrongdoing in the medical suits case and said it was forced to act due to Zhumadilov's own mismanagement of the situation.

URGENT NEED

The row comes at a testing time for Ukraine, which has so far reported 21,245 cases of COVID-19, the lung disease caused by the new coronavirus, with 623 deaths. Medics accounted for about a fifth of Ukraine's cases, highlighting the urgent need for more protective suits.

Last month MPU conducted a tender and awarded the contract to Textil-Kontakt, which had already supplied suits to hospitals. But the government voided the deal, saying Textil's gear offered no better protection than a painter's overalls and lacked the proper certification.

"(Doctors) need personal protective equipment. If, instead of a biological protection suit, a house painter's overall is bought … well, I'm sorry," Health Minister Maksym Stepanov told Reuters.

Textil and Zhumadilov said Textil's suits fulfilled health ministry criteria. It had already made around 23,500 suits when the contract was cancelled, said Textil founder Oleksandr Sokolovsky.

The government then awarded the contract to a firm called Meddiv, which charged 489 hryvnias ($18) per suit, compared to Textil's 245 hryvnias.

Meddiv did not respond to Reuters' request for comment.

Meddiv imported the suits from China, causing weeks of delay, and as of May 19 only around 29,000 had arrived in Ukraine, according to customs documents published by an opposition lawmaker.

Meddiv's lack of experience in handling larger contracts or overseas shipments should have excluded it from the bidding process, Zhumadilov said.

"Our anti-corruption officer said that according to our procedures this company could not have qualified for our tender," he added.

© Reuters. Employees sew protective suits at the Textile-Contact company's factory in Chernihiv

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.